Abbott has made a global commitment to combat HIV and AIDS since the onset of this epidemic in the early 1980s. Today, Abbott is recognized as a leader in AIDS research, having developed major diagnostic and treatment advances for HIV and AIDS patients. Our commitment to fighting this deadly disease includes the best weapon developed so far education. Abbott produces Norvir™ (ritonavir).
ALZA Corporation, headquartered in Palo Alto, Calif., is an emerging pharmaceutical company with leading drug delivery technologies. ALZA produces NeuTrexin® (trimetrexate glucuronate). With concurrent leucovorin protection , it provides an alternate treatment for moderate- to-severe Pneumocystis carinii pneumonia (PCP), in immunocompromised patients who are intolerant of, or refractory to, trimethoprim-sulfamethoxazole therapy. PCP is the most common life-threatening infection associated with AIDS.
The world's largest independent biotechnology company, Amgen, was founded in Thousand Oaks, California in 1980 as AMGen (Applied Molecular Genetics). Amgen currently has three products on the market: EPOGEN® (Epoetin alfa), NEUPOGEN® (Filgrastim) and INFERGEN® (Interferon alfacon-1).
Aventis Pasteur is a leader in vaccination informs you on immunology, each vaccine, vaccinations (STD, virus protection, polio…) and vaccines news (cancer research, AIDS..).
Headquartered in Ingelheim (Germany) ranks among the top 20 pharmaceutical companies in the world. The corporation has some 160 affiliated companies and it conducts business on every continent. Its product range is focused on human pharmaceuticals - hospital, prescription and self-medication - as well as animal health. Boehringer Ingelheim produces and markets Viramune® (nevirapine) world-wide while it's affiliate, Roxane Laboratories, markets Viramune® in the U.S.
The Mission of Bristol-Myers Squibb is to extend and enhance human life by providing the highest-quality health and personal care products. Bristol-Myers Squibb produces Videx® (didanosine also known as ddI) and Zerit® (stavudine, also known as d4T).
Chiron Corporation is a science-driven healthcare company headquartered in Emeryville, California, near San Francisco. A recombinant gp120 vaccine developed by Chiron Vaccines is being tested in Phase 2 clinical trials in the U.S. and is being studied in Thailand. A new "prime-plus-boost" strategy using Chiron's gp120 vaccine in combination with Pasteur-Merieux' canarypox vector, is being tested in Phase 2 clinical trials.
Ciba Vision is the developer of Vitravene™. Vitravene™ is indicated for the local treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS), who are intolerant of or have a contraindication to other treatment(s) for CMV retinitis or who were insufficiently responsive to previous treatment(s) for CMV retinitis.
Eli Lilly and Company is a global research-based pharmaceutical corporation dedicated to creating and delivering innovative pharmaceutical-based health care solutions that enable people to live longer, healthier and more active lives.
Genentech's mission is to be the leading biotechnology company, using human genetic information to develop, manufacture and market pharmaceuticals that address significant unmet medical needs.
Geron is the leading biotechnology company focused on human aging. Its mission is to develop novel therapeutics for the many manifestations of aging through breakthroughs in the basic genetic mechanism of cell aging and immortalization.
An independent biopharmaceutical company whose employees share one common goal: providing accelerated solutions for patients and the people who care for them. Gilead produces VISTIDE® (cidofovir injection) for the treatment of CMV retinitis, a sight-threatening infection in patients with AIDS. Gilead's most advanced product in the pipeline is PREVEON® (adefovir dipivoxil), currently in late-stage clinical testing for the potential treatment of HIV infection.
GlaxoSmithKline is a research-based company whose people are committed to fighting disease by bringing innovative medicines and services to patients throughout the world, and to the healthcare providers who serve them. Glaxo produces AZT, Epivir (3tc), and Combivir
Hybridon (OTC:Bulletin Board - HYBN) is a leader in the discovery and development of novel genetic medicines based primarily on antisense technology. Produces the antisense drug GEM 92.
Interferon Sciences, Inc. is a biopharmaceutical company engaged in the study, manufacture and sale of pharmaceutical products based on its highly purified, natural-source, multispecies alpha interferon (Natural Alpha Interferon). Produces Alferon.
Isis Pharmaceuticals has developed an oligonucleotide (a short piece of a DNA-like compound) which can bind to and interfere with the decoding of the DNA of CMV. This oligonucleotide is targeted specifically to CMV genetic information so it can shut down CMV but does not interfere with the functioning of human DNA. This compound is called ISIS 2922.
The Liposome Company, Inc. is a leading biotechology company dedicated to the development and commercialization of proprietary lipid- and liposome-based pharmaceuticals.
Merck & Co., Inc. is a leading research-driven pharmaceutical products and services company. Merck discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health. Merck produces Crixivan® (indinavir sulfate).
Pharmacia Corporation was created in April 2000 through the merger of Pharmacia & Upjohn with Monsanto Company and its G.D. Searle unit. Pharmacia employs 59,000 people worldwide and has research, manufacturing and administrative sales operations in more than 60 countries. Produces RESCRIPTOR® (delavirdine mesylate).
TargetHIVFusion.com is an educational Web site designed to help people living with HIV learn more about the new classes of antiviral drugs that will target the "entry" steps of the HIV replication process. This site is brought to you by the Roche-Trimeris alliance — a partnership dedicated to the advancement of anti-HIV therapy through research and development in the entry inhibitor class of drugs.
Serono is a fully-integrated company in the business of creating and providing specialty pharmaceuticals which, combined with our customer education and support programs, achieve new therapeutic solutions. Produces human growth hormone Serostim.
Introducing PREZISTA™ (darunavir) is a prescription medication called a protease inhibitor. PREZISTA does not cure HIV infection or AIDS, and does not prevent passing HIV to others. Ask your doctor if PREZISTA is right for you.
Vertex Pharmaceuticals is engaged in the discovery, development and commercialization of novel, small molecule pharmaceuticals for the treatment of diseases for which there are currently limited or no effective treatment. Produces Amprenavir.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
